Skip to content

The influence of intraoperative esketamine infusion combined with stellate ganglion block on sleep quality after gynecological laparoscopic surgery

The influence of intraoperative esketamine infusion combined with stellate ganglion block on sleep quality after gynecological laparoscopic surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500101846
Enrollment
Unknown
Registered
2025-04-30
Start date
2025-05-01
Completion date
Unknown
Last updated
2025-05-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None

Interventions

Normal saline group:The right stellate ganglion block is not performed before the operation. During the operation, an equal volume of 0.9% sodium chloride is infused until the end of the operation
Esketamine group:The right stellate ganglion block is not performed before the operation. During the operation, esketamine is continuously pumped at a dose of 0.3mg/kg/h until the end of the operation
Esketamine + Stellate ganglion block group:Before induction, the right stellate ganglion block is performed. During the operation, esketamine is continuously pumped at a dose of 0.3mg/kg/h until the e

Sponsors

Affiliated Hospital of Xuzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1.Age: 18-75 years; 2. Body Mass Index (BMI): 18-29.5 kg/m^2; 3. ASA: I - III; 4. Patients undergoing elective gynecological laparoscopic surgery.

Exclusion criteria

Exclusion criteria: 1. Pre-existing sleep disorders with a Pittsburgh Sleep Quality Index (PSQI) score greater than 5; 2. Severe hypertension, diabetes, and cerebrovascular diseases; 3. Long-term use of sedatives or antidepressants; 4. History of motion sickness, smoking, and alcohol dependence; 5. Previous neurological, psychiatric, or psychological conditions that prevent cooperation or understanding of the scale content; 6. Recent history of drug abuse; 7. Refusal to participate; 8. Allergy to or contraindications for the trial medication; 9. Contraindications for regional anesthesia: abnormal clotting function, infection at the puncture site, allergy to local anesthetics, etc.

Design outcomes

Primary

MeasureTime frame
The incidence of sleep disorders 48 hours after the operation;

Secondary

MeasureTime frame
Anxiety and Depression Index;Postoperative sleep structure;Pittsburgh sleep quality index(PSQI)score;Postoperative VAS scores;Quality of recovery-15 (QoR-15) score;Postoperative nausea and vomiting rate;Postoperative gastrointestinal function;Time to first flatus;The number of flatulence within 48 hours after the operation;The usage of perioperative analgesic drugs; Hemodynamic parameters (systolic blood pressure, diastolic blood pressure, mean arterial pressure, heart rate);The usage of vasoactive drugs;Postoperative estimated incidence rate;The satisfaction of patients;Length of postoperative hospital stay;

Countries

China

Contacts

Public ContactMengxing Jia

Department of Anesthesiology, Affiliated Hospital of Xuzhou Medical University

xzmu_jiamengxing@126.com+86 158 9523 8016

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026